Results 91 to 100 of about 316,243 (290)
British Journal of Clinical Pharmacology, EarlyView.Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source
Health Science ReportsBackground and Aims Interventions to address potentially inappropriate prescribing (PIP), where risks outweigh benefits, are effective but often not implemented due to barriers (e.g., patient, provider, systems).
Nav Persaud +4 more
doaj +1 more source
Does Cost Sharing really Reduce Inappropriate Prescriptions? [PDF]
This paper explores different empirical strategies to examine the effect of cost sharing for prescription drugs in some dimensions of medication-related quality, namely the probability of inappropriate prescription drug use among United States seniors ...
Marin Gemmill-Toyama, Joan Costa-i-Font
core
British Journal of Clinical Pharmacology, EarlyView.Abstract Aim To identify safety concerns reported by coroners following fentanyl patch‐related deaths in England, Wales and Northern Ireland, and determine differences in coronial reporting. Methods A systematic case series linking the National Programme on Substance Use Mortality (NPSUM) and the Preventable Deaths Tracker (PDT) (https ...
Eman Mshari +2 more
wiley +1 more source
Antibiotics in Primary Care: Factors Leading to Inappropriate Prescribing [PDF]
, 2011 Purpose: The purpose of this paper is to explore common factors leading to inappropriate antibiotic prescribing in the primary care setting. The research demonstrated that nearly half of all antibiotic prescriptions given in primary care are unnecessary;
Hosey, Melissa Christine
core +2 more sources
, 2018 Definition of the prescribing quality indicators divided into indicators focusing on recommended treatment and inappropriate prescribing and their included number of patients and outcomes.
Nanne Kleefstra (153070) +8 more
core +1 more source
Ceftriaxone‐induced liver injury: Incidence, phenotypic characterization and predictive factors
British Journal of Clinical Pharmacology, EarlyView.Introduction Ceftriaxone is a widely used third‐generation cephalosporin in hospitalized patients. Although generally considered safe, it has been associated with hepatobiliary complications and emerging reports of drug‐induced liver injury (DILI). However, data on its true incidence, phenotypic patterns, and predictors remain limited. This study aimed
Mohamed Hatem +5 more
wiley +1 more source
, 2023 We propose a scoping review focused on assessing gender and gender-related sociocultural variables as it pertains to potentially inappropriate medication prescribing in older ...
Joelle Li
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aim Pancreatic enzyme replacement therapy (PERT) is essential for the management of pancreatic exocrine insufficiency. Since June 2023, the United Kingdom has been affected by a global shortage of PERT. We investigated the impact of this shortage on national prescribing trends for Creon, Nutrizym, Pancrex and Pangrol.
Teena S. Varghese +6 more
wiley +1 more source
Prescribing safety: the case of inappropriate medicines [PDF]
British Journal of General Practice, 2011 ![][1] Prescribing is a common outcome of many general practice consultations, and is the principle therapeutic intervention offered by the NHS. It is essential that this critical activity is clinically effective, cost-effective, and safe. Rates of prescribing are increasing year-on-year, with the average person in England receiving 17.8 prescription
openaire +3 more sources